Expanded Access Program (EAP) in Leber's Hereditary Optic Neuropathy (LHON) Patients Treated for 24 Months (Slides)

Update Item Information
Identifier 20200310_nanos_sciplatform3_06-slides
Title Expanded Access Program (EAP) in Leber's Hereditary Optic Neuropathy (LHON) Patients Treated for 24 Months (Slides)
Creator Thomas Klopstock; Xavier Llòria; Magda Silva; Rudolph Guenther; Felice Lob; Bettina Von Livonius; Claudia Catarino
Affiliation (TK) Friedrich-Baur-Institute, Dept. of Neurology University of Munich, MUNICH, Germany; (XL) (MS) Santhera Pharmaceuticals Ltd, Pratteln, Switzerland, Pratteln, Switzerland; (RG) (FL) (BV) (CC) Dep of Ophthalmology, University Hospital of the Ludwig-Maximilians University, Munich, Germany
Subject Optic Neuropathy
Description LHON is a mitochondrial genetic disorder resulting in severe bilateral central VA loss. Three primary mitochondrial DNA mutations cause over 90% of cases. Data from idebenone EAP for patients with LHON receiving treatment for at least 24 months were analyzed to assess rate of clinically-relevant recovery (CRR).
Date 2020-03
Language eng
Format application/pdf
Type Text
Source 2020 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2020: Scientific Platform Session III
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2020. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6bs422s
Setname ehsl_novel_nam
ID 1541358
Reference URL https://collections.lib.utah.edu/ark:/87278/s6bs422s
Back to Search Results